Advertisement
 
News
Subscribe to Drug Discovery & Development News

The Lead

Baxter's Orphan Drug Candidate Hits Key Phase 3 Endpoint

April 16, 2014 | Comments

Baxter International Inc. announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics of BAX 111, a recombinant von Willebrand factor under investigation for the treatment of bleeding episodes in patients with von Willebrand disease. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

HPV Vaccine Works in HIV+ Women

April 16, 2014 2:00 pm | Comments

HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial, countering doubts about whether the vaccine would be helpful. Read more...

TOPICS:

Small Molecule Shows Potential in Advanced Cancers

April 16, 2014 1:34 pm | Comments

Cleveland BioLabs Inc. announced the achievement of all objectives in a Phase 1 clinical trial of CBL0102, or quinacrine, an orally administered small molecule in patients with advanced cancers for which no standard care exists or which had become resistant to conventional therapies. Read more...

TOPICS:

Researchers ID New Formulation for Cancer Treatment

April 16, 2014 11:20 am | Comments

Researchers have discovered a new way to deliver a tricky drug, dichloroacetate, that may one day make it a viable treatment for numerous forms of cancer. Read more...                       

TOPICS:
Advertisement

3-D Printed Tissues May Aid Drug Delivery, Wound Healing

April 16, 2014 11:13 am | Comments

A University of Oxford spin-out, OxSyBio, will develop 3-D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. Read more...                       

TOPICS:

Drug Developers Using New Models, Methods to Boost Clinical Success Rates

April 16, 2014 11:05 am | Comments

Drug companies and their development partners who are seeking to increase clinical success rates of new drug candidates are developing tools to help them predict the likelihood of marketing approval and incorporating business planning earlier in clinical development, according to new evidence. Read more...

TOPICS:

SSRI Use During Pregnancy Linked to Autism, Developmental Delays

April 16, 2014 10:57 am | Comments

In a study of nearly 1,000 mother-child pairs, researchers found that prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) was associated with autism spectrum disorder (ASD) and developmental delays (DD) in boys. Read more...   

TOPICS:

Judge Blocks Zohydro Ban in Massachusetts

April 16, 2014 10:47 am | by Steve LeBlanc | Comments

A federal judge has blocked Massachusetts from banning the powerful new painkiller Zohydro after the maker of the drug, Zogenix, argued in a lawsuit that the ban ordered by Gov. Deval Patrick last month is unconstitutional. Read more...    

TOPICS:

FDA Approves GSK's Injectable Diabetes Drug

April 16, 2014 10:00 am | Comments

The FDA said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The agency cleared the company's drug, Tanzeum, to help patients control their blood sugar levels, in combination with diet and exercise. Read more...

TOPICS:
Advertisement

Breaking News: EMA Warns of Falsified Herceptin

April 16, 2014 9:09 am | Comments

The EMA has been informed that vials of the cancer medicine Herceptin, thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries. Read more...

TOPICS:

2014 R&D 100 Awards Entry Deadline Extended

April 15, 2014 3:09 pm | Comments

The editors of R&D Magazine have announced that there is still plenty time to prepare your Entry Form for the 2014 R&D 100 Awards: Friday, May 2 is the new deadline.                      

New Product Launches Lift J&J in Q1

April 15, 2014 1:05 pm | by Linda Johnson, AP Business Writer | Comments

The world's biggest maker of health care products, such as Tylenol, medical devices and prescription drugs, easily beat Wall Street expectations and raised its earnings outlook, driving up its shares to a new high for the year. Read more...

TOPICS:

FDA Approves Merck’s Allergy Immunotherapy

April 15, 2014 12:59 pm | Comments

Merck announced that the FDA has approved Grastek (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use, an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis. Read more...   

TOPICS:

Protein Partnership Inflames Immune Cells in Cancer

April 15, 2014 12:53 pm | Comments

Scientists have identified two unlikely partners in a type of immune cell called a macrophage that work together in response to cancer drugs to increase inflammation in a way that may alter tumor growth. Read more...         

TOPICS:

CBR Starts Cerebral Palsy Stem Cell Study

April 15, 2014 12:45 pm | Comments

Cord Blood Registry (CBR) announced the launch of an FDA-regulated clinical trial being conducted at The University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy. Read more...

TOPICS:

AbbVie’s Lung Cancer Drug Advances to Phase 3

April 15, 2014 12:20 pm | Comments

AbbVie announced the initiation of a global Phase 3 clinical trial evaluating the safety and efficacy of its investigational compound, veliparib, in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading